Merck chicken bronchitis vaccine approved for use in China
Merck chicken bronchitis vaccine approved for use in China BEIJING, May 27 (Reuters) - Merck MRK.N said its vaccine against bronchitis in chickens has been approved by the Chinese agriculture ministry for use in the world's largest chicken-rearing country, which is home to over 5 billion birds.
Any chicks that hatch today can be vaccinated from Thursday, with the live vaccine formulation suitable for chickens aged 1 day and above, the U.S. company said on Wednesday.
The vaccine targets infectious chicken bronchitis strain 4-91, a highly contagious chicken coronavirus first identified in Britain in the early 1990s.
Side effects of chicken bronchitis typically include reduced egg production and coughing, according to the US National Institutes of Health research institute.
Chicken bronchitis has a “high mutation rate and rapid transmission,” Zhang Guozhong, a professor at China Agricultural University, said in the statement, warning of "severe and complex" epidemic risks across flocks.
(Reporting by Joe Cash;Editing by Elaine Hardcastle)
((Joe.Cash@thomsonreuters.com;))
Recent news on Merck & Co
See all newsU.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Eli Lilly, Pfizer slip after US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials (updated)
Brief: U.S. House Committee Sends Letters To Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials